GlobeNewsWire · BBIO · November 11, 2026
BridgeBio to Present New Acoramidis Data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: GlobeNewsWire ↗